Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
DJI Avata 360, First 8K 360-Degree FPV Drone Announced, More Info at B&H Photo Video
-
Aprea Therapeutics Announces Oversubscribed $30 Million Private Placement
-
Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease
-
CCC Intelligent Solutions Adds All Clear to Diagnostics Network
-
Stop & Shop Celebrates Spring with Seasonal Savings & A Free In-Store Offer
-
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Sagtec Global (NASDAQ: SAGT) to Launch Sovereign AI Data Center Powered by NVIDIA GPU Architecture; Infrastructure Pivot to Support Millions of Daily F&B Retail Ordering, Retail and Fintech Transa
-
SEALSQ joins ECHONET Consortium as PKI Services provider to Strengthen IoT Security in Smart Home and Energy Networks in Japan
-
Nano Labs Announces Second Half of 2025 Financial Results
-
Rezolve Ai Delivers 543% H2 Growth; Raises 2026 Revenue Guidance to $360M as Platform Achieves Global Infrastructure Scale
-
Lotus For Me SUV Officially Launches: Redefining Performance and Versatility with X-Hybrid Technology
-
Tokyo Lifestyle Partners with BrainAurora to Develop Integrated Platform for Cognitive Impairment and Functional Health Products in Japan and Southeast Asia
-
JE Cleantech Secures approximately USD$12 million
-
HTVRONT Launches D2 DTF Printer to Simplify Small Business Production with a More “Worry-Free” Start
-
Aprea Therapeutics Highlights Positive Emerging Clinical Activity for WEE1 Inhibitor, APR-1051, with a Confirmed Partial Response in the Ongoing Phase 1 ACESOT-1051 Trial
-
Consumer Passions and Priorities Give Lifestyle Spending New Significance, Reports Circana
-
Lianhe Sowell International Group Ltd. Announces $1.8 Million Contract to Develop AI Steam Car‑Wash Robot Promising Significant Water Savings
-
Terra Innovatum Enhances Leadership for Commercial Scale-Up with Appointment of Former AREVA CEO and CFO Kathy Williams
-
Standard Lithium Reports Fourth Quarter and Full Year 2025 Results
-
DJI Avata 360, First 8K 360-Degree FPV Drone Announced, More Info at B&H Photo Video
-
VisionWave Provides Corporate Update on Planned Expansion of Multi-Domain Intelligence Platform Across Defense, Energy, and Autonomous Systems
-
Journal of Urology Publishes ENVISION Trial Results Showing 72.2% 24-Month Duration of Response with ZUSDURI
-
BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease
-
Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting
-
Stop & Shop Celebrates Spring with Seasonal Savings & A Free In-Store Offer
-
FDH Electronics Launches New eCommerce Website
-
Chiesi Global Rare Diseases Receives Positive CHMP Opinion for LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolemia (HoFH)
-
Arax Investment Partners Adds Omni Financial Advisory Group
-
Willis launches new facility to address limited umbrella capacity in U.S. casualty market
-
Westwood Real Estate Income Fund Celebrates 25-Year Anniversary
-
Esperion Showcases New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) at the American College of Cardiology’s Annual Scientific Session 2026
-
JazzCash Onboards Its 1 Millionth Merchant on Pakistan’s National Digital Payments Platform, Advancing the Country’s Cashless Economy
-
ASML reports transactions under its current share buyback program
-
Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress
-
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
-
Nasdaq Concludes Public Consultation on Nasdaq-100 Index® Methodology
-
Director/PDMR Shareholding
-
Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis
-
Novo Nordisk A/S - share repurchase programme
-
Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates
-
Virtuix Signs Cooperative Research and Development Agreement with U.S. Navy
-
MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue
-
Fancamp Acquires Iron Ore Royalty and Provides Corporate Update
-
MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue
-
WISeKey’s WISeSat.Space Subsidiary Successfully Launches Its 21st Satellite to Low Earth Orbit with SpaceX
-
Elevar Therapeutics Announces FDA Acceptance for Review of New Drug Application for Lirafugratinib as Second-line Cholangiocarcinoma Treatment
-
Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic Challenges of Microcystic Lymphatic Malformations
-
SEED Therapeutics Announces Poster Presentation at AACR Annual Meeting 2026
-
Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204
-
Drilling intersects 92.6 metres (m) of 0.95 g/t gold
